Insider Transactions in Q4 2023 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2023
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
714
-4.75%
|
$64,260
$90.0 P/Share
|
|
Dec 22
2023
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
714
+4.53%
|
$5,712
$8.8 P/Share
|
|
Dec 15
2023
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
3,914
-8.02%
|
$328,776
$84.35 P/Share
|
|
Dec 15
2023
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,654
+10.02%
|
$3,654
$1.87 P/Share
|
|
Dec 13
2023
|
Philina Lee CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
261
+0.82%
|
$261
$1.87 P/Share
|
|
Dec 11
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-2.76%
|
$395,000
$79.07 P/Share
|
|
Dec 11
2023
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.69%
|
$180,000
$36.05 P/Share
|
|
Dec 07
2023
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
5,000
-16.95%
|
$375,000
$75.0 P/Share
|
|
Dec 07
2023
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+14.49%
|
$270,000
$54.13 P/Share
|
|
Dec 04
2023
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
600
-2.39%
|
$42,600
$71.43 P/Share
|
|
Nov 30
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-2.76%
|
$350,000
$70.55 P/Share
|
|
Nov 30
2023
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.69%
|
$180,000
$36.05 P/Share
|
|
Nov 24
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
15,000
-4.01%
|
$1,005,000
$67.53 P/Share
|
|
Nov 24
2023
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+7.28%
|
$15,000
$1.87 P/Share
|
|
Nov 03
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
1,485
-0.84%
|
$89,100
$60.13 P/Share
|
|
Nov 03
2023
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
1,485
+0.83%
|
$53,460
$36.05 P/Share
|
|
Nov 02
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
4,634
-1.28%
|
$278,040
$60.71 P/Share
|
|
Nov 02
2023
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
4,634
+2.5%
|
$166,824
$36.05 P/Share
|
|
Nov 01
2023
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
3,881
-2.16%
|
$232,860
$60.02 P/Share
|
|
Nov 01
2023
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
3,881
+2.11%
|
$139,716
$36.05 P/Share
|
|
Oct 26
2023
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
600
-2.34%
|
$33,600
$56.4 P/Share
|
|
Oct 04
2023
|
Fouad Namouni PRESIDENT, R & D |
SELL
Open market or private sale
|
Direct |
3,769
-5.72%
|
$180,912
$48.06 P/Share
|